Anhui Hongxiang Pharmaceutical Technology Co., Ltd.

This trial used levofloxacin hydrochloride injection as the control drug, and preliminarily evaluated the safety and efficacy of 400 mg QD dosing regimen of levofloxacin hydrochloride injection in the treatment of community-acquired pneumonia through a multicenter, randomized, double-blind, parallel-controlled clinical trial, providing a basis for the design of the Phase III clinical trial.

This trial used levofloxacin hydrochloride injection as the control drug, and preliminarily evaluated the safety and efficacy of 400 mg QD dosing regimen of levofloxacin hydrochloride injection in the treatment of pyelonephritis through a multicenter, randomized, double-blind, parallel-controlled clinical trial method, providing a basis for the design of the Phase III clinical trial protocol.